Newsfeeds Archive - Spark Newswire

1 minute read

June 20, 7:28 AM

SAN DIEGO, and CALGARY, AB, June 20, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology,

ONCY

5 minute read

Earnings

Earnings Scheduled For November 3, 2023

By Benzinga Insights

November 3, 7:12 AM

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.

ACRE

1 minute read

Earnings

Oncolytics Biotech’s Earnings Outlook

By Benzinga Insights

November 2, 3:01 PM

Oncolytics Biotech (NASDAQ:ONCY) is set to give its latest quarterly earnings report on Friday, 2023-11-03. Here’s what investors…

ONCY

4 minute read

The Pancreatic Cancer Action Network Selects Oncolytics Biotech Inc. To Receive $5M Therapeutic Accelerator Award To Develop Leading-Edge Treatments

By Benzinga Newsdesk

September 26, 8:01 AM

Innovative Multimillion-Dollar Grant Was Created in 2022 to Drive Biopharma Industry to Speed Development of Pancreatic Cancer TherapiesBOSTON and SAN DIEGO and CALGARY, AB, Sept. 26, 2023 /PRNewswire/ -- In an effort to

ONCY

12 minute read

Earnings

Earnings Scheduled For August 14, 2023

By Benzinga Insights

August 14, 6:45 AM

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

AAMC

1 minute read

Earnings

Oncolytics Biotech’s Earnings: A Preview

By Benzinga Insights

August 11, 11:01 AM

Oncolytics Biotech (NASDAQ:ONCY) is set to give its latest quarterly earnings report on Monday, 2023-08-14. Here’s what investors…

ONCY

2 minute read

Analyst Ratings

5 Analysts Have This to Say About Oncolytics Biotech

By Benzinga Insights

June 29, 3:00 PM

Analysts have provided the following ratings for Oncolytics Biotech (NASDAQ:ONCY) within the last quarter: Bullish Somewhat Bullish Indifferent…

ONCY

4 minute read

Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

June 22, 1:09 PM

Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private investment positions.

$APE

2 minute read

News

Pancreatic Cancer Action Network Urges Advocates From All 50 States To Call On Congress To Increase Federal Funding For Pancreatic Cancer Research

By Benzinga Newsdesk

June 14, 9:13 AM

Federal Funding Increases Fuel Research Progress and Help Improve Patient OutcomesLOS ANGELES, June 14, 2023 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading pancreatic cancer patient

ARAV